{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:09:46Z","timestamp":1761581386469},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/mnm.0000000000000481","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T07:42:35Z","timestamp":1453880555000},"page":"593-601","source":"Crossref","is-referenced-by-count":7,"title":["Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET\/CT in breast cancer patients"],"prefix":"10.1097","volume":"37","author":[{"given":"Kusai M.","family":"Al-Muqbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami J.","family":"Yaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u2019moon H.","family":"Al-Omari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqa A.","family":"Rousan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawaf M.","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Al Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210212","first-page":"352","article-title":"Recurrent and metastatic breast cancer PET, PET\/CT, PET\/MRI: FDG and new biomarkers","volume":"57","author":"Gaeta","year":"2013","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R2-6-20210212","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2007.11.2854","article-title":"Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography\/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer","volume":"25","author":"Du","year":"2007","journal-title":"J Clin Oncol"},{"key":"R3-6-20210212","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.cr.7290266","article-title":"Mechanisms of cancer metastasis to the bone","volume":"15","author":"Yin","year":"2005","journal-title":"Cell Res"},{"key":"R4-6-20210212","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R5-6-20210212","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"R6-6-20210212","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/RLU.0b013e31815f23b7","article-title":"Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer","volume":"33","author":"Shie","year":"2008","journal-title":"Clin Nucl Med"},{"key":"R7-6-20210212","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-005-1869-x","article-title":"Osteoblastic bone metastases in breast cancer: is not seeing believing?","volume":"32","author":"Fogelman","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-6-20210212","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00259-006-0141-3","article-title":"FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy","volume":"33","author":"Israel","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-6-20210212","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","article-title":"Mechanisms of osteolytic bone metastases in breast carcinoma","volume":"97","author":"K\u00e4k\u00f6nen","year":"2003","journal-title":"Cancer"},{"key":"R10-6-20210212","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00259-005-1842-8","article-title":"Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancr","volume":"32","author":"Nakai","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-6-20210212","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF02985050","article-title":"Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer","volume":"19","author":"Abe","year":"2005","journal-title":"Ann Nucl Med"},{"key":"R13-6-20210212","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","article-title":"Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions","volume":"16","author":"Cook","year":"1998","journal-title":"J Clin Oncol"},{"key":"R14-6-20210212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2471070567","article-title":"Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET\/CT","volume":"247","author":"Tateishi","year":"2008","journal-title":"Radiology"},{"key":"R15-6-20210212","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2214\/ajr.184.4.01841266","article-title":"Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer","volume":"184","author":"Uematsu","year":"2005","journal-title":"Am J Roentgenol"},{"key":"R16-6-20210212","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/RLU.0b013e3181a7d03c","article-title":"Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET","volume":"34","author":"Huyge","year":"2009","journal-title":"Clin Nucl Med"},{"key":"R17-6-20210212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12149-011-0538-3","article-title":"FDG-avid sclerotic bone metastases in breast cancer patients: a PET\/CT case series","volume":"26","author":"Koolen","year":"2012","journal-title":"Ann Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000000481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:34:07Z","timestamp":1620963247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201606000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000000481","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}